Global Nutraceutical Excipients Market Size Grows at a CAGR of 7.6%

Introduction

Straits Research today released its highly anticipated report, “Nutraceutical Excipients Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 5.60 billion in 2025 and is projected to expand to USD 10.80 billion by 2034 registering a compound annual growth rate (CAGR) of 7.60%.

Market Dynamics

The nutraceutical excipients market is growing steadily due to the rise of clean-label supplements, sugar-reduced formulations, and innovative delivery formats such as gummies, shots, and delayed-release capsules. This shift is driven by consumer preference for products that balance health benefits with convenience and taste. Additionally, regulatory clarity, such as the FDA's updated guidance on dietary supplement ingredients in 2025, has strengthened the demand for high-quality, traceable excipients with proven safety and stability data. For instance, in April 2025, Ashland expanded its plant-based film coating line in Brazil to support clean-label tablets tailored for the North American and South American markets, highlighting the industry's adaptation to regional compliance and consumer trends.

However, the market also faces challenges. Rising scrutiny around nitrosamine contamination in cellulose-based excipients has led to tighter specifications and increased quality-control costs. Smaller supplement brands may struggle to adapt to these higher compliance standards, which can slow product launches and reformulations. Despite these hurdles, strong opportunities are emerging, especially in advanced dosage forms. For example, in 2025, Evonik’s launch of EUDRACAP colon-targeted capsules enabled the creation of next-generation gut-health supplements, supporting precision delivery and enhancing consumer trust. These developments signal a broader transition toward functional excipients that drive both product differentiation and long-term category growth.

Key Highlights

• By Function: According to Straits Research, the binders and fillers dominated the market in 2025, with a revenue share of 27%.
• By Dosage Form: The gummies segment is estimated to register the fastest CAGR growth of 10.5%.
• By Source: The Synthetic excipients category dominated the market in 2025 with a revenue share of 36%.
• By End User: The Contract Manufacturers or CDMOs  segment is projected to register the fastest CAGR of 9.8% during the forecast period.
• Regional Insights: North America dominates with over 37.40% share, driven by well-advanced Neutraceutical Excipients infrastructure across the region.

Competitive Players

1. Roquette (incl. Qualicaps)
2. Evonik Health Care
3. Ashland
4. Colorcon
5. BASF Nutrition & Health / LDC Ingredients (post-transaction)
6. DFE Pharma
7. JRS Pharma
8. MEGGLE
9. Shin-Etsu Chemical
10. Gattefossé
11. Lubrizol Life Science – Health
12. Ingredion
13. Kerry Group
14. Tate & Lyle
15. DSM-Firmenich
16. Lonza Capsules & Health
17. ACG
18. Qualicaps
19. CapsCanada
20. IMCD
21. SPI Pharma
22. DuPont/IFF

Recent Developments

• April 2025 - Ashland completed a USD 10 million expansion at Cabreúva, adding Aquarius tablet-coating and microbial-protection capability to support the Americas' supply and faster launches of sugar-reduced tablets.

Segmentation

1. By Function (2026-2034)
   1. Binders and fillers
   2. Disintegrants
   3. Coatings and film formers
   4. Lubricants and glidants
   5. Sweeteners and flavour systems
   6. Solubilisers and emulsifiers
   7. Preservatives and antioxidants
   8. Controlled-release polymers
   9. Colorants
   10. Other carriers
2. By Dosage Form (2026-2034)
   1. Tablets
   2. Capsules
   3. Gummies and chewables
   4. Powders and sachets
   5. RTD liquids and shots
   6. Softgels and liquid-fill
3. By Source (2026-2034)
   1. Synthetic
   2. Plant-based
   3. Mineral
   4. Animal-derived
4. By End User (2026-2034)
   1. Nutraceutical brand owners
   2. Contract manufacturers/CDMOs
   3. Private label/retail brands
   4. Clinical nutrition companies
5. By Region (2026-2034)
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East and Africa
   5. Latin America